The risk of catching Marburg virus is described as “extremely low” by the NHS. Symptoms can typically take three to 10 days ...
For the first time in Rwanda’s history, its health ministry is dealing with an outbreak of Marburg virus disease, a rare but deadly hemorrhagic disease similar to Ebola – but unlike Ebola, there is no ...
Rwanda begins vaccine trials amid fears of outbreak of deadly disease - Virus kills around half of people it infects ...
In the last few weeks, Rwanda has witnessed a sharp rise in the number of cases associated with one of the deadliest viruses ...
Rwanda said on Sunday it had begun administering vaccine doses against the Marburg virus to try to combat an outbreak of the Ebola-like disease in the east African country, where it has so far killed ...
Marburg hemorrhagic fever has killed 11 people in Rwanda, health authorities said Thursday, as the East African country searches for the source of an outbreak first traced among patients in health ...
Health officials in Rwanda are dealing with the country’s first outbreak of the Marburg virus, an Ebola-like disease which, ...
Don't miss out! Tick this box to receive great Christian content from Premier and others, keep up to date and hear about ways you can support our work. You can unsubscribe anytime. Find out more about ...
The Lord Venkateswara Temple in Andhra Pradesh's Tirupati was "purified" Monday amid the row over animal fat - fish oil, beef tallow, and lard (pig fat) - in ghee used to make the laddoos ...
LA JOLLA, CA-At this moment, the world has few tools to combat deadly filoviruses, such as Ebola and Marburg viruses. The only approved vaccine and antibody treatments protect against just one ...
Targeting Ebola virus—and more As Watanabe explains, targeting the nucleocapsid spells "game over" for the virus. "If you don't have a nucleocapsid, nothing can happen. That's the core of the ...
The 2014 Ebola epidemic in West Africa serves as a stark reminder of the vulnerabilities and strengths of public health systems. As the world continues to face emerging and re-emerging infectious ...